Who holds it, who is betting against it, and where the big money is moving
Net of large-order buying minus selling, in USD. Over this window: −$6.52M (5 inflow days, 15 outflow days).
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 47.9% of shares outstanding.
Reported short interest has risen from 16.87% to 20.69% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +184,116 | 0.3% |
| Newtyn Management, LLC | Hedge Fund | 2026/Q3 | +2,066,528 | 9.7% |
| Paradigm Capital Management, Inc. | Mutual Fund | 2026/Q3 | +995,800 | 3.7% |
| Buckley Capital Advisors, LLC | Hedge Fund | 2026/Q3 | +850,335 | 1.2% |
| FMR | Mutual Fund | 2026/Q3 | +770,795 | 10.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +753,396 | 16.3% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +720,763 | 1.3% |
| Private Management Group Inc | Mutual Fund | 2026/Q3 | +685,622 | 3.0% |
| Van Lanschot Kempen Investment Management N.V. | Mutual Fund | 2026/Q3 | +647,069 | 0.9% |
| Gagnon Securities, LLC | Mutual Fund | 2026/Q3 | +627,046 | 1.5% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +450,947 | 4.8% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +440,263 | 1.1% |
| Eaton Vance Management | Mutual Fund | 2026/Q3 | +344,141 | 0.7% |
| Morgan Stanley | Public Company | 2026/Q3 | +307,874 | 1.7% |
| Gem Investment Advisors, LLC | Mutual Fund | 2026/Q3 | +269,333 | 0.8% |
Institutional buy/sell activity by reporting period, largest moves first.
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | Ronald Bowman | Chief Human Resources Officer | Derivative Exercise and Sale | -921 | $10.63 | 5,020 |
| 14 Sep 2026 | Ronald Bowman | Chief Human Resources Officer | Derivative Exercise and Retained | +1,645 | – | 5,020 |
| 14 Aug 2026 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Sale | -162 | $14.30 | 8,055 |
| 14 Aug 2026 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Retained | +284 | – | 8,055 |
| 14 Jul 2026 | Micah Young | Chief Financial Officer & Principal Financial Officer | Other Derivative Acquisition | +356,555 | – | 356,555 |
| 30 Jun 2026 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Sale | -2,096 | $18.18 | 7,771 |
| 30 Jun 2026 | Bryan Hanson | Senior Vice President of Clinical Labs & Transfusion Medicine | Derivative Exercise and Retained | +3,701 | – | 7,771 |
| 24 Jun 2026 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +369 | – | 369 |
| 24 Jun 2026 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +3,698 | – | 3,698 |
| 24 Jun 2026 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +15,532 | – | 15,532 |
| 24 Jun 2026 | Kenneth Widder | Independent Director | Other Derivative Acquisition | +1,997 | – | 1,997 |
| 24 Jun 2026 | Kenneth Widder | Independent Director | Other Derivative Acquisition | +6,656 | – | 6,656 |
| 24 Jun 2026 | Kenneth Widder | Independent Director | Other Derivative Acquisition | +15,532 | – | 15,532 |
| 24 Jun 2026 | Kenneth Buechler | Independent Non-Executive Chairperson | Other Derivative Acquisition | +3,661 | – | 3,661 |
| 24 Jun 2026 | Kenneth Buechler | Independent Non-Executive Chairperson | Other Derivative Acquisition | +12,204 | – | 12,204 |
| 24 Jun 2026 | Kenneth Buechler | Independent Non-Executive Chairperson | Other Derivative Acquisition | +15,532 | – | 15,532 |
| 24 Jun 2026 | Edward Michael | Independent Director | Other Derivative Acquisition | +1,053 | – | 1,053 |
| 24 Jun 2026 | Edward Michael | Independent Director | Other Derivative Acquisition | +3,513 | – | 3,513 |
| 24 Jun 2026 | Edward Michael | Independent Director | Other Derivative Acquisition | +15,532 | – | 15,532 |
| 24 Jun 2026 | Mary Polan | Independent Director | Other Derivative Acquisition | +1,664 | – | 1,664 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 15 Sep 2026 | 14,190,525 | 20.7% | 10.8 |
| 31 Aug 2026 | 14,128,210 | 20.6% | 10.5 |
| 14 Aug 2026 | 14,962,267 | 21.8% | 7.6 |
| 31 Jul 2026 | 13,005,131 | 19.1% | 12.7 |
| 15 Jul 2026 | 11,802,749 | 17.3% | 9.8 |
| 30 Jun 2026 | 11,505,504 | 16.9% | 5.4 |
No comments yet — be the first to weigh in on QDEL.